PGP and cancer: First, the cytotoxicity of glesatinib to P-gp overexpressing cancer cells KB-C2, SW620/Ad300, HEK293/ABCB1, and their parent cells KB-3-1, SW620, HEK293 cells were determined by MTT assay.